Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness...
Ausführliche Beschreibung
Autor*in: |
Cai, Nan [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Umfang: |
10 |
---|
Übergeordnetes Werk: |
Enthalten in: Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study - Ha, Diep H ELSEVIER, 2022, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:26 ; year:2016 ; pages:309-318 ; extent:10 |
Links: |
---|
DOI / URN: |
10.1016/j.jff.2016.08.014 |
---|
Katalog-ID: |
ELV024386898 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV024386898 | ||
003 | DE-627 | ||
005 | 20230623173736.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jff.2016.08.014 |2 doi | |
028 | 5 | 2 | |a GBVA2016009000004.pica |
035 | |a (DE-627)ELV024386898 | ||
035 | |a (ELSEVIER)S1756-4646(16)30224-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 630 |a 640 |a 610 | |
082 | 0 | 4 | |a 630 |q DE-600 |
082 | 0 | 4 | |a 640 |q DE-600 |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.96 |2 bkl | ||
100 | 1 | |a Cai, Nan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
264 | 1 | |c 2016 | |
300 | |a 10 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. | ||
700 | 1 | |a Xie, Shu-Juan |4 oth | |
700 | 1 | |a Qiu, Dong-Bo |4 oth | |
700 | 1 | |a Jia, Chang-Chang |4 oth | |
700 | 1 | |a Du, Cong |4 oth | |
700 | 1 | |a Liu, Wei |4 oth | |
700 | 1 | |a Chen, Jia-Jie |4 oth | |
700 | 1 | |a Zhang, Qi |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Ha, Diep H ELSEVIER |t Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV007989776 |
773 | 1 | 8 | |g volume:26 |g year:2016 |g pages:309-318 |g extent:10 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.jff.2016.08.014 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.96 |j Zahnmedizin |q VZ |
951 | |a AR | ||
952 | |d 26 |j 2016 |h 309-318 |g 10 | ||
953 | |2 045F |a 630 |
author_variant |
n c nc |
---|---|
matchkey_str |
cainanxieshujuanqiudongbojiachangchangdu:2016----:oetaefcsfagsiitervninntetetf |
hierarchy_sort_str |
2016 |
bklnumber |
44.96 |
publishDate |
2016 |
allfields |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
spelling |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
allfields_unstemmed |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
allfieldsGer |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
allfieldsSound |
10.1016/j.jff.2016.08.014 doi GBVA2016009000004.pica (DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 DE-627 ger DE-627 rakwb eng 630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Cai, Nan verfasserin aut Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma 2016 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. Xie, Shu-Juan oth Qiu, Dong-Bo oth Jia, Chang-Chang oth Du, Cong oth Liu, Wei oth Chen, Jia-Jie oth Zhang, Qi oth Enthalten in Elsevier Ha, Diep H ELSEVIER Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study 2022 Amsterdam [u.a.] (DE-627)ELV007989776 volume:26 year:2016 pages:309-318 extent:10 https://doi.org/10.1016/j.jff.2016.08.014 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.96 Zahnmedizin VZ AR 26 2016 309-318 10 045F 630 |
language |
English |
source |
Enthalten in Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study Amsterdam [u.a.] volume:26 year:2016 pages:309-318 extent:10 |
sourceStr |
Enthalten in Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study Amsterdam [u.a.] volume:26 year:2016 pages:309-318 extent:10 |
format_phy_str_mv |
Article |
bklname |
Zahnmedizin |
institution |
findex.gbv.de |
dewey-raw |
630 |
isfreeaccess_bool |
false |
container_title |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
authorswithroles_txt_mv |
Cai, Nan @@aut@@ Xie, Shu-Juan @@oth@@ Qiu, Dong-Bo @@oth@@ Jia, Chang-Chang @@oth@@ Du, Cong @@oth@@ Liu, Wei @@oth@@ Chen, Jia-Jie @@oth@@ Zhang, Qi @@oth@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
ELV007989776 |
dewey-sort |
3630 |
id |
ELV024386898 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024386898</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623173736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jff.2016.08.014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016009000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024386898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1756-4646(16)30224-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">640</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.96</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cai, Nan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xie, Shu-Juan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qiu, Dong-Bo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jia, Chang-Chang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Du, Cong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Wei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Jia-Jie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Qi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Ha, Diep H ELSEVIER</subfield><subfield code="t">Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007989776</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:309-318</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jff.2016.08.014</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.96</subfield><subfield code="j">Zahnmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2016</subfield><subfield code="h">309-318</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">630</subfield></datafield></record></collection>
|
author |
Cai, Nan |
spellingShingle |
Cai, Nan ddc 630 ddc 640 ddc 610 bkl 44.96 Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
authorStr |
Cai, Nan |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007989776 |
format |
electronic Article |
dewey-ones |
630 - Agriculture & related technologies 640 - Home & family management 610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
topic |
ddc 630 ddc 640 ddc 610 bkl 44.96 |
topic_unstemmed |
ddc 630 ddc 640 ddc 610 bkl 44.96 |
topic_browse |
ddc 630 ddc 640 ddc 610 bkl 44.96 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
s j x sjx d b q dbq c c j ccj c d cd w l wl j j c jjc q z qz |
hierarchy_parent_title |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
hierarchy_parent_id |
ELV007989776 |
dewey-tens |
630 - Agriculture 640 - Home & family management 610 - Medicine & health |
hierarchy_top_title |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV007989776 |
title |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
ctrlnum |
(DE-627)ELV024386898 (ELSEVIER)S1756-4646(16)30224-9 |
title_full |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
author_sort |
Cai, Nan |
journal |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
journalStr |
Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
zzz |
container_start_page |
309 |
author_browse |
Cai, Nan |
container_volume |
26 |
physical |
10 |
class |
630 640 610 630 DE-600 640 DE-600 610 DE-600 610 VZ 44.96 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Cai, Nan |
doi_str_mv |
10.1016/j.jff.2016.08.014 |
dewey-full |
630 640 610 |
title_sort |
potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
title_auth |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
abstract |
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. |
abstractGer |
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. |
abstract_unstemmed |
• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma |
url |
https://doi.org/10.1016/j.jff.2016.08.014 |
remote_bool |
true |
author2 |
Xie, Shu-Juan Qiu, Dong-Bo Jia, Chang-Chang Du, Cong Liu, Wei Chen, Jia-Jie Zhang, Qi |
author2Str |
Xie, Shu-Juan Qiu, Dong-Bo Jia, Chang-Chang Du, Cong Liu, Wei Chen, Jia-Jie Zhang, Qi |
ppnlink |
ELV007989776 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth |
doi_str |
10.1016/j.jff.2016.08.014 |
up_date |
2024-07-06T21:18:03.397Z |
_version_ |
1803866009394741248 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024386898</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623173736.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jff.2016.08.014</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016009000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024386898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1756-4646(16)30224-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">640</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.96</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cai, Nan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• α-Mangostin inhibited the proliferation of HCC and transformed hepatic cells. • α-Mangostin reversed doxorubicin-resistance in the HCC cells induced by IL-6. • α-Mangostin reduced the percentage of CD133 and CD44 positive stem-like HCC cells. • α-Mangostin suppressed the expression of key stemness transcription factors.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xie, Shu-Juan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qiu, Dong-Bo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jia, Chang-Chang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Du, Cong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Wei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Jia-Jie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Qi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Ha, Diep H ELSEVIER</subfield><subfield code="t">Group-based trajectories of maternal intake of sugar-sweetened beverage and offspring oral health from a prospective birth cohort study</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007989776</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:26</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:309-318</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jff.2016.08.014</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.96</subfield><subfield code="j">Zahnmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">26</subfield><subfield code="j">2016</subfield><subfield code="h">309-318</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">630</subfield></datafield></record></collection>
|
score |
7.3994865 |